List of Excipients in API methylphenidate extended-release
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing methylphenidate extended-release
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Neos Therapeutics LP | METHYLPHENIDATE EXTENDED-RELEASE | methylphenidate extended-release | 62542-100 | CELLULOSE, MICROCRYSTALLINE | |
| Neos Therapeutics LP | METHYLPHENIDATE EXTENDED-RELEASE | methylphenidate extended-release | 62542-100 | CITRIC ACID MONOHYDRATE | |
| Neos Therapeutics LP | METHYLPHENIDATE EXTENDED-RELEASE | methylphenidate extended-release | 62542-100 | CROSPOVIDONE | |
| Neos Therapeutics LP | METHYLPHENIDATE EXTENDED-RELEASE | methylphenidate extended-release | 62542-100 | ETHYLCELLULOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for methylphenidate extended-release
Excipient focus: CELLULOSE, MICROCRYSTALLINE
methylphenidate extended-release drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
methylphenidate extended-release drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
methylphenidate extended-release drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
methylphenidate extended-release drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FRUCTOSE
methylphenidate extended-release drug variants containing FRUCTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing FRUCTOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
methylphenidate extended-release drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
methylphenidate extended-release drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID
methylphenidate extended-release drug variants containing METHACRYLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing METHACRYLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
methylphenidate extended-release drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSTYRENE SULFONIC ACID
methylphenidate extended-release drug variants containing POLYSTYRENE SULFONIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing POLYSTYRENE SULFONIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
methylphenidate extended-release drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
methylphenidate extended-release drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
methylphenidate extended-release drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Neos Therapeutics LP | methylphenidate extended-release | 62542-100 |
| >Company | >Ingredient | >NDC |
methylphenidate extended-release drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch